2.82

10.76% -0.34

Pre-market: 2.84 0.02 +0.71%

Nexalin Technology Inc (NXL)

Overview News Price History Financials Discussions Forecast

Nexalin Technology Inc stock is traded at $2.82, with a volume of 398.25K. It is down -10.76% in the last 24 hours and up +7.22% over the past month. Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Previous Close:

$3.16

Open:

$3.17

24h Volume:

398.25K

Relative Volume:

0.24

Market Cap:

$37.52M

Revenue:

$128.60K

Net Income/Loss:

$-4.60M

P/E Ratio:

-4.4762

EPS:

-0.63

Net Cash Flow:

$-3.74M

1W Performance:

+1.44%

1M Performance:

+7.22%

6M Performance:

+127.42%

1Y Performance:

+529.61%

1-Day Range:

$2.82

$3.25

1-Week Range:

$2.5501

$3.32

52-Week Range:

$0.2528

$4.4899

Nexalin Technology Inc Stock (NXL) Company Profile

Name

Nexalin Technology Inc

Sector

Healthcare (1176)

Industry

Medical Devices (162)

Phone

(832) 260-0222

Address

1776 YORKTOWN, HOUSTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

NXL's Discussions on Twitter

Compare NXL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NXL Nexalin Technology Inc	2.82	37.52M	128.60K	-4.60M	-3.74M	-0.63
ABT Abbott Laboratories	116.79	201.01B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	395.85	150.90B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	100.91	148.72B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	88.38	113.33B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	69.97	41.27B	6.60B	4.16B	490.10M	6.93

Nexalin Technology Inc Stock (NXL) Latest News

Jan 15, 2025

Nexalin Technology CEO Mark White Issues Letter to - GlobeNewswire

Jan 15, 2025

Jan 14, 2025

Nexalin Technology CEO sends letter to shareholders - TipRanks

Jan 14, 2025

Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025 - The Manila Times

Jan 14, 2025

Nexalin's Revolutionary DIFS Technology Shows 65% Success Rate in Depression Treatment - StockTitan

Jan 14, 2025

Jan 01, 2025

Certain Common Stock of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. - Marketscreener.com

Jan 01, 2025

Certain Options of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. - Marketscreener.com

Jan 01, 2025

Dec 27, 2024

Nexalin Technology (NASDAQ:NXL) Shares Up 5.5% – Here’s What Happened - Defense World

Dec 27, 2024

Dec 25, 2024

How Do Things Look For Nexalin Technology Inc (NASDAQ: NXL) In The Short-Term? - Stocks Register

Dec 25, 2024

Dec 23, 2024

Nexalin Technology, Inc. Launches Phase 1 of AI-Driven Virtual Clinic to Enhance Mental Health Treatment - Nasdaq

Dec 23, 2024

Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic - GlobeNewswire

Dec 23, 2024

Nexalin Technology, Inc. Completes Phase 1 of Its Innovative Virtual Clinic - Marketscreener.com

Dec 23, 2024

Dec 19, 2024

Target Corp (TGT-N) QuotePress Release - The Globe and Mail

Dec 19, 2024

Walmart Inc (WMT-N) QuotePress Release - The Globe and Mail

Dec 19, 2024

Dec 07, 2024

Maxim Group Reaffirms Hold Rating for Nexalin Technology (NASDAQ:NXL) - Defense World

Dec 07, 2024

Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities - MSN

Dec 07, 2024

Dec 06, 2024

Nexalin Technology downgraded to Hold from Buy at Maxim - MSN

Dec 06, 2024

Dec 05, 2024

Maxim Group Downgrades Nexalin Technology (NXL) - MSN

Dec 05, 2024

Nexalin Technology Stock Soars to All-Time High of $4.4 Amidst Stunning Growth - Investing.com Canada

Dec 05, 2024

Dec 02, 2024

Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World

Dec 02, 2024

Nov 28, 2024

Nexalin Technology, Inc. (NASDAQ:NXL) Short Interest Update - MarketBeat

Nov 28, 2024

Nov 26, 2024

New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market - Marketscreener.com

Nov 26, 2024

Nexalin Technology announces peer-reviewed publication on DIFS technology - Nasdaq

Nov 26, 2024

New Peer-Reviewed Publication Validates Nexalin’s Deep - GlobeNewswire

Nov 26, 2024

Nexalin's Brain Stimulation Tech Breakthrough Validated in Major Medical Journal | NXL Stock News - StockTitan

Nov 26, 2024

Nov 25, 2024

Alibaba Group Holding ADR (BABA-N) QuotePress Release - The Globe and Mail

Nov 25, 2024

Nov 13, 2024

Nexalin Technology stock soars to all-time high of $4.07 - Investing.com

Nov 13, 2024

Nexalin Technology stock soars to all-time high of $4.07 By Investing.com - Investing.com UK

Nov 13, 2024

Nov 11, 2024

Nexalin Technology CEO Provides Letter to Shareholders - GlobeNewswire

Nov 11, 2024

Nexalin's Breakthrough: Alzheimer's Studies Show Promise, Secures Key Brain Tech Patent | NXL Stock News - StockTitan

Nov 11, 2024

Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 ResultsCERo Therapeutics Hldgs (NASDAQ:CERO) - Benzinga

Nov 11, 2024

Nov 10, 2024

Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth? - Yahoo Finance

Nov 10, 2024

Nov 08, 2024